Skip to content

Investment Purchases at other companies

Gilead Sciences logo
Gilead SciencesGILD
$525M
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$101.69M+102%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$7.77M+379%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$139.09M+138,993%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$20.14M-84.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$452.25M+1,714%

Other financials

Income statement

See full
Revenue-
Operating income-$24.4M-10.2%
Net income-$23.5M-15.8%
EPS (diluted)-$0.95-14.5%

Balance sheet

See full
Cash & equivalents$21.4M-30.6%
Total debt$10.3M-26.7%
Total equity$87.8M-48.0%
Total assets$106.0M-44.6%

Cash flow

See full
Operating cash flow-$21.0M-5.6%
CapEx$242.0K-52.6%
Free cash flow-$21.2M-4.1%

Valuation

See full
Market cap$429.03M+1,015%
Enterprise value$417.88M+1,832%

Profitability

See full
Operating margin-83.9%
Net margin-79.3%

Returns & leverage

See full
Return on equity-67.9%
Debt / equity0.1×0.0×
Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s investment purchases?
Artiva Biotherapeutics, Inc. (ARTV) reported investment purchases of $6.44M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s investment purchases changed year-over-year?
Artiva Biotherapeutics, Inc.'s investment purchases decreased by 65.2% year-over-year, from $18.52M to $6.44M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.